Nanoparticles exposing neurotensin tumor-specific drivers

Tyrosine kinase inhibitors in acute and chronic leukemias

(2012) Maro Ohanian et al.   EXPERT OPINION ON PHARMACOTHERAPY

Branched peptides as novel tumor-targeting agents for bladder cancer

(2012) Andrea Minervini et al.   Expert Review of Anticancer Therapy

Target-Selective Drug Delivery through Liposomes Labeled with Oligobranched Neurotensin Peptides

(2011) Chiara Falciani et al.   ChemMedChem

SAR3419: An Anti-CD19-Maytansinoid Immunoconjugate for the Treatment of B-Cell Malignancies

(2011) V. Blanc et al.   CLINICAL CANCER RESEARCH

Antibody-Radionuclide Conjugates for Cancer Therapy: Historical Considerations and New Trends

(2011) M. Steiner et al.   CLINICAL CANCER RESEARCH

Design and In vitro Evaluation of Branched Peptide Conjugates: Turning Nonspecific Cytotoxic Drugs into Tumor-Selective Agents

(2010) Chiara Falciani et al.   ChemMedChem

Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept

(2010) C. Falciani et al.   CURRENT CANCER DRUG TARGETS

Peptide-Mediated Liposomal Drug Delivery System Targeting Tumor Blood Vessels in Anticancer Therapy

(2010) Han-Chung Wu et al.   Journal of Oncology

Oligo-branched peptides for tumor targeting: from magic bullets to magic forks

(2009) Chiara Falciani et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case

(2009) Roberto Ronca et al.   IMMUNOBIOLOGY

Antibody-targeted liposomes in cancer therapy and imaging

(2008) Stavroula Sofou et al.   Expert Opinion on Drug Delivery

Antibody-modified liposomes for cancer chemotherapy

(2008) Vladimir Torchilin   Expert Opinion on Drug Delivery

Investigation into the Role of Tumor-Associated Macrophages in the Antitumor Activity of Doxil

(2008) Manuela Banciu et al.   PHARMACEUTICAL RESEARCH